Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
500 participants
INTERVENTIONAL
2018-08-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients
NCT04135014
Clinical Study of Oral Midazolam Combined With Esketamine Administered Intranasally for Pediatric Preoperative Sedation
NCT05925283
Effects of Nasal Administration of Dexmedetomidine on Pre-anesthesia Sedation, Intraoperative Brain Electrical Activity, and Incidence of Agitation During Recovery in Children
NCT06896721
Comparing Two Doses of Midazolam With Added Dexmedetomidine for Kids Before Surgery
NCT06979791
Handheld-multimedia Versus Oral Midazolam in Pediatric on Perioperative Anxiety
NCT04273035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anxiolytics
Pediatric patients treated with sedation using anxiolytics
Midazolam/diazepam/propofol
Therapeutic drug monitoring of anxiolytics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Midazolam/diazepam/propofol
Therapeutic drug monitoring of anxiolytics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age:≤18 years;
* Patients with therapeutic concentration monitoring of anxiolytics.
Exclusion Criteria
* The blood concentrations of the patient was not approved by the quality control center
* Use foods or products that inhibit or induce CYP 3A activity.
29 Days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wei Zhao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wei Zhao
Professor; Head of department of clinical pharmacy and pharmacology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shandong Provincial Qianfoshan Hospital
Ji'nan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-anxiolytics-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.